Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Amaral

Showing results (11-20 of 307) with videos related to

Pageof 31
Sort By:
Current Opinion in Pharmacology|March 7, 2022
Precision medicine for rare diseases: The times they are A-Changin'Margarida D Amaral
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 1, 2020
Letter to the editor of JCFMargarida D Amaral
Biochimica Et Biophysica Acta|January 14, 1970
New substrate for galactose oxidaseG T Zancan, D Amaral
Trends in Pharmacological Sciences|June 19, 2007
Molecular targeting of CFTR as a therapeutic approach to cystic fibrosisMargarida D Amaral, Karl Kunzelmann
Cellular and Molecular Life Sciences : CMLS|April 22, 2020
A central role of the endoplasmic reticulum in the cell emerges from its functional contact sites with multiple organellesCelso Almeida, Margarida D Amaral
Canadian Journal of Microbiology|September 1, 1977
Carbon source dependent differences in the composition of the cell walls of the basidiomycete Picnoporus cinnabarinusJ A Cury, D Amaral
Journal of General Microbiology|September 1, 1975
Regulation of fructose uptake by glucose in Escherichia coliD Amaral, H L Kornberg
FEBS Letters|June 27, 2025
Cystic fibrosis as a paradigmatic disease in bringing science to the bedsideMargarida D Amaral, Ines Pankonien
Molecular Diagnosis & Therapy|January 27, 2026
Author's Reply to Yang and Wang: "Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models"Margarida D Amaral, Ines Pankonien
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 26, 2024
Theranostics vs theratyping or theranostics plus theratyping?Margarida D Amaral, Ines Pankonien
Pageof 31

Showing results (11-20 of 307) with videos related to

Sort By:
Pageof 31
Current Opinion in Pharmacology|March 7, 2022
Precision medicine for rare diseases: The times they are A-Changin'Margarida D Amaral
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 1, 2020
Letter to the editor of JCFMargarida D Amaral
Biochimica Et Biophysica Acta|January 14, 1970
New substrate for galactose oxidaseG T Zancan, D Amaral
Trends in Pharmacological Sciences|June 19, 2007
Molecular targeting of CFTR as a therapeutic approach to cystic fibrosisMargarida D Amaral, Karl Kunzelmann
Cellular and Molecular Life Sciences : CMLS|April 22, 2020
A central role of the endoplasmic reticulum in the cell emerges from its functional contact sites with multiple organellesCelso Almeida, Margarida D Amaral
Canadian Journal of Microbiology|September 1, 1977
Carbon source dependent differences in the composition of the cell walls of the basidiomycete Picnoporus cinnabarinusJ A Cury, D Amaral
Journal of General Microbiology|September 1, 1975
Regulation of fructose uptake by glucose in Escherichia coliD Amaral, H L Kornberg
FEBS Letters|June 27, 2025
Cystic fibrosis as a paradigmatic disease in bringing science to the bedsideMargarida D Amaral, Ines Pankonien
Molecular Diagnosis & Therapy|January 27, 2026
Author's Reply to Yang and Wang: "Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models"Margarida D Amaral, Ines Pankonien
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 26, 2024
Theranostics vs theratyping or theranostics plus theratyping?Margarida D Amaral, Ines Pankonien
Pageof 31